WUXI APPTEC(02359.HK): 2026 Nine-Month Report - Profit Attributable to Shareholders stood at CNY 19.16 billion, YoY increase of 62.36%
NewTimeSpace News: October 26, 2026, WUXI APPTEC(02359.HK) released its Nine-Month Report for the period ended December 31, 2026, Total Revenue stood at CNY 45.54 billion, increased by 38.59% YoY; Net Profit stood at CNY 19.27 billion, YoY increase of 61.49%; Profit Attributable to Shareholders stood at CNY 19.16 billion, YoY increase of 62.36%; Basic Earnings Per Share (EPS) stood at CNY 6.58.
In terms of profitability, WUXI APPTEC Gross Profit changed from CNY 15.12 billion in the same period last year to CNY 24.38 billion in the current period, increased by CNY 9.26 billion; gross profit margin changed from 46.01% in the same period last year to 53.54% in the current period, increased by 7.52 percentage points; net profit changed from CNY 11.93 billion in the same period last year to CNY 19.27 billion in the current period, increased by CNY 7.34 billion; net profit margin changed from 36.31% in the same period last year to 42.31% in the current period, increased by 6 percentage points.
In terms of earnings quality, WUXI APPTEC Operating Profit changed from CNY 14.58 billion in the same period last year to CNY 23.77 billion in the current period, increased by CNY 9.2 billion; Operating Profit Margin changed from 44.37% in the same period last year to 52.21% in the current period, increased by 7.84 percentage points; Net Cash Flow from Operating Activities changed from cash inflow of CNY 10.87 billion in the same period last year to cash inflow of CNY 16.61 billion in the current period, increased by CNY 5.74 billion; Ratio of Net Cash Flow from Operating Activities to Total Operating Revenue changed from 33.09% in the same period last year to 36.47% in the current period, increased by 3.38 percentage points.
In terms of financial soundness, WUXI APPTEC Debt-to-Asset Ratio changed from 24.45% in the same period last year to 22.13% in the current period, decreased by 2.32 percentage points; Total Equity changed from CNY 71.472 billion in the same period last year to CNY 97.454 billion in the current period, increased by CNY 25.98 billion; Cash and Cash Equivalents changed from CNY 25.476 billion in the same period last year to CNY 29.526 billion in the current period, increased by CNY 4.05 billion; Current Liabilities changed from CNY 19.44 billion in the same period last year to CNY 23.85 billion in the current period, increased by CNY 4.41 billion; Quick Ratio changed from 2.46 in the same period last year to 3.01 in the current period, increased by 0.55 percentage points.
In terms of R&D investment focus, WUXI APPTEC R&D Expenses changed from CNY 825.65 million in the same period last year to CNY 923.4 million in the current period, increased by CNY 97.75 million; R&D to Total Revenue Ratio changed from 2.51% in the same period last year to 2.03% in the current period, decreased by 0.48 percentage points.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Implementation of the Pharmaceutical Industry Development “15th Five-Year Plan” and Standout Data for Domestic Novel Drugs at WCLC: Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) Rose 10.82%
- WUXI APPTEC (02359.HK): US Court Grants Preliminary Injunction, Company Shielded from Immediate Adverse Effects While Challenging DoD 1260H Designation
- HK Stock Connect Weekly Report: Earnings catalysts resonate with policy dividends, "innovative drugs + large models" dual mainlines unfold in HK Stock Connect - 20260807
- WUXI APPTEC(02359.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 11.08 billion, YoY increase of 33.7%
- WUXI APPTEC(02359.HK) will spend CNY 99.97 million to repurchase 858.71 thousand shares on Jun 25, 2026